Keep tabs on your favorite ETFs with a personalized weekly tracker. Create a Watchlist now →
TMEDvsFTXHETF Comparison
T. Rowe Price Health Care ETF (TMED) and First Trust Nasdaq Pharmaceuticals ETF (FTXH) belong to the same industry segment: US Health Care. TMED's top 3 sector exposures are Health Care and Financials. In contrast, FTXH's top sector exposures are Health Care TMED is less expensive with a Total Expense Ratio (TER) of 0.44%, versus 0.6% for FTXH. TMED is up 0.94% year-to-date (YTD) with +$3M in YTD flows. FTXH performs better with 5.06% YTD performance, and +$7M in YTD flows. Run a side-by-side ETF comparison of TMED and FTXH below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
TMED vs FTXH performance and flow charts
Performance
Cumulative Flows
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | TMED FTXH | +1.63%-0.60% | +3.73%+7.47% | +0.94%+5.06% | n/a+22.29% | n/a+43.33% | n/a+43.47% |
| Flows | TMED FTXH | +$1M+$5M | +$4M+$9M | +$3M+$7M | -+$10M | --$13M | -+$4M |
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | TMED FTXH | +16.68%+15.29% | n/a+20.64% | n/a+15.87% | n/a+15.67% |
| Max drawdown | TMED FTXH | -7.14%-4.33% | n/a-17.49% | n/a-19.32% | n/a-19.32% |
| Max drawdown duration | TMED FTXH | 46d9d | n/a203d | n/a393d | n/a393d |
TMED | FTXH | |
Last sale 3/11/2026 at 1:30 PM | $29.57 | $34.46 |
| Previous close 03/10/2026 | $29.70 | $34.57 |
| Consolidated volume 03/10/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Create an account to view replication metrics
TMED | FTXH | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
TMED | FTXH | |
|---|---|---|
| Last price | $29.57 | $34.46 |
| 1D performance | -0.42% | -0.33% |
| AuM | $19.47 M | $29.41 M |
| E/R | 0.44% | 0.6% |
TMED | FTXH | |
|---|---|---|
| Management strategy | Active | Passive |
| Provider | T. Rowe Price | First Trust |
| Benchmark | - | NASDAQ US Smart Pharmaceuticals Index |
| N° of holdings | 74 | 49 |
| Asset class | - | Equities |
| Trailing 12m distribution yield | Join | Join |
| Inception date | June 11, 2025 | September 20, 2016 |
| ESG | No | No |
Countries
Sectors
Diversification
Total weight of top 15 holdings out of 15
Total weight of top 15 holdings out of 15
Top 15 holdings
How have the TMED and FTXH ETFs performed in 2026?
As of March 9, 2026, TMED is up 0.94% year-to-date (YTD), while FTXH has returned 5.06%. That puts FTXH better performer ahead so far this year.
Which ETF is attracting more investor money: TMED or FTXH?
Year-to-date, the TMED ETF saw +$3M in flows, compared to +$7M for FTXH.
Which ETF is bigger: TMED or FTXH?
As of March 9, 2026, TMED holds $19.47 M in assets under management (AUM), while FTXH manages $29.41 M.
What sectors do the TMED and FTXH ETFs invest in?
TMED leans toward sectors like Health Care. Meanwhile, FTXH focuses on Health Care.
What are the top holdings of the TMED ETF and FTXH ETF?
TMED top holdings include LILLY, UNITEDHEALTH GRP and GILEAD SCIENCES. FTXH holds in its top three: MERCK & CO INC, JOHNSON&JOHNSON and BRISTOL-MYERS SQUIBB.
Which ETF is more diversified: TMED or FTXH?
TMED holds 80 securities with 56.46% of its assets in the top 15. FTXH has 50 securities and a top 15 weight of 71.63%.
Active Trader Report: Use of Leveraged & Inverse ETFs Way Up
Direxion partnered with Compound Insights and Vanda to explore what’s driving the evolution of active trading — and how active traders are using leveraged and inverse funds across equities, single stocks, commodities, and volatility.
